Research and Molecular Discovery

The Research and Molecular Discovery team at Disarm Therapeutics is responsible for identifying and developing novel molecular targets and therapeutic compounds that can prevent axonal degeneration. This team integrates cutting-edge neuropharmacological and molecular biology techniques to drive preclinical research, advancing drug candidates from the discovery phase toward clinical development for treating neurological diseases such as multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies.